Assessment of Early Pregnancy MAB Completion

Not yet recruiting

• Conditions: Pregnancy; Abortion Early

• Registration Number: NCT06893484
• Lead Sponsor: University of Washington

Brief Summary

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-03
• Study Start: 2025-03
• Study First Submitted: 2025-03-09
• Study First Submitted QC: 2025-03-17
• Last Update Submitted: 2025-03-17
• Study First Posted: 2025-03-25
• Last Update Posted: 2025-03-25
• Primary Completion: 2026-03
• Study Completion: 2026-04

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 400

Inclusion Criteria

• Pregnant person with early pregnancy ≤42 days
• Eligible and consented to a medication abortion
• Have access to receiving text messages and the internet
• Able to read and understand English

Exclusion Criteria

• Privacy or safety concerns about filling out the surveys

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of participants with negative high-sensitivity urine pregnancy test at 2 weeks	From time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnaires	To estimate the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 2 weeks after taking Mifepristone and compare this proportion to the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 4 weeks

Secondary Outcome Measures

Name	Time	Method
Time to resolution of pregnancy symptoms	From time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnaires	To compare the timing of pregnancy symptom resolution per patient report on weekly questionnaires with the timing of a negative high-sensitivity urine pregnancy test result